litlas
ログインアカウント作成

Jeffrey S. Wefel

2003–2025 年に発表

77
論文数
19,309
被引用数
58
h 指数
74
i10 指数

被引用数

Jeffrey S. Wefel の年別被引用数1993 年: 被引用 3 件2004 年: 被引用 2 件2005 年: 被引用 20 件2006 年: 被引用 21 件2007 年: 被引用 33 件2008 年: 被引用 54 件2009 年: 被引用 35 件2010 年: 被引用 71 件2011 年: 被引用 72 件2012 年: 被引用 112 件2013 年: 被引用 131 件2014 年: 被引用 208 件2015 年: 被引用 228 件2016 年: 被引用 200 件2017 年: 被引用 229 件2018 年: 被引用 195 件2019 年: 被引用 690 件2020 年: 被引用 763 件2021 年: 被引用 736 件2022 年: 被引用 605 件2023 年: 被引用 400 件2024 年: 被引用 720 件2025 年: 被引用 308 件2026 年: 被引用 10 件1994〜2003 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 2,031 件、この内訳の 29.8%中国: 引用元論文 557 件、この内訳の 8.2%ドイツ: 引用元論文 419 件、この内訳の 6.2%カナダ: 引用元論文 362 件、この内訳の 5.3%イタリア: 引用元論文 321 件、この内訳の 4.7%オランダ: 引用元論文 317 件、この内訳の 4.7%イギリス: 引用元論文 314 件、この内訳の 4.6%フランス: 引用元論文 274 件、この内訳の 4%スイス: 引用元論文 221 件、この内訳の 3.2%オーストラリア: 引用元論文 200 件、この内訳の 2.9%日本: 引用元論文 163 件、この内訳の 2.4%スペイン: 引用元論文 153 件、この内訳の 2.3%
0%29.8%その他 21.7%

機関

分野

  • Medicine82.6%
  • Biochemistry, Genetics and Molecular Biology8.3%
  • Neuroscience2.9%
  • Immunology and Microbiology1.8%
  • Engineering1%
  • Materials Science0.9%
  • その他2.5%

トピック

  • Glioma Diagnosis and Treatment16.4%
  • Brain Metastases and Treatment14.2%
  • Cancer-related cognitive impairment studies7.9%
  • Lung Cancer Research Studies4.2%
  • Cancer survivorship and care3.2%
  • Lung Cancer Treatments and Mutations1.9%
  • その他52.2%

共著者

全論文

検索で開く
  1. A Randomized Trial of Bevacizumab for Newly Diagnosed Glioblastoma

    著者: Mark R. Gilbert, James J. Dignam, Terri S. Armstrong, Jeffrey S. Wefel, Deborah T. Blumenthal, Michael A. Vogelbaum, Howard Colman, Arnab Chakravarti, Stephanie L. Pugh, Minhee Won, Robert Jeraj, Paul D. Brown, Kurt A. Jaeckle, David Schiff, Volker W. Stieber, David Brachman, Maria Werner‐Wasik, Ivo W. Tremont‐Lukats, Erik P. Sulman, Kenneth Aldape, Walter J. Curran, Minesh P. Mehta - New England Journal of Medicine 2014 被引用: 2,793

  2. Dose-Dense Temozolomide for Newly Diagnosed Glioblastoma: A Randomized Phase III Clinical Trial

    著者: Mark R. Gilbert, Meihua Wang, Kenneth Aldape, Roger Stupp, Monika E. Hegi, Kurt A. Jaeckle, Terri S. Armstrong, Jeffrey S. Wefel, Minhee Won, Deborah T. Blumenthal, Anita Mahajan, Christopher J. Schultz, Sara Erridge, Brigitta G. Baumert, Kristen I. Hopkins, Tzahala Tzuk-Shina, Paul D. Brown, Arnab Chakravarti, Walter J. Curran, Minesh P. Mehta - Journal of Clinical Oncology 2013 被引用: 1,074

  3. Hippocampal Avoidance During Whole-Brain Radiotherapy Plus Memantine for Patients With Brain Metastases: Phase III Trial NRG Oncology CC001

    著者: Paul D. Brown, Vinai Gondi, Stephanie L. Pugh, Wolfgang A. Tomé, Jeffrey S. Wefel, Terri S. Armstrong, Joseph Bovi, Clifford G. Robinson, André Konski, Deepak Khuntia, David R. Grosshans, Tammie L.S. Benzinger, Deborah Watkins Bruner, Mark R. Gilbert, David Roberge, Vijayananda Kundapur, Kiran Devisetty, Sunjay Shah, Kenneth Y. Usuki, Bethany Anderson, Baldassarre Stea, Harold Yoon, Jing Li, Nadia N. Laack, Tim J. Kruser, Steven J. Chmura, Wenyin Shi, Snehal Deshmukh, Minesh P. Mehta, Lisa A. Kachnic, for NRG Oncology - Journal of Clinical Oncology 2020 被引用: 830

  4. Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation: a randomised controlled trial

    著者: Eric L. Chang, Jeffrey S. Wefel, Kenneth R. Hess, Pamela K. Allen, Frederick F. Lang, David Kornguth, Rebecca Arbuckle, J. Michael Swint, Almon S. Shiu, Moshe Maor, Christina A. Meyers - The Lancet Oncology 2009 被引用: 2,478

  5. International Cognition and Cancer Task Force recommendations to harmonise studies of cognitive function in patients with cancer

    著者: Jeffrey S. Wefel, Janette L. Vardy, Tim A. Ahles, Sanne B. Schagen - The Lancet Oncology 2011 被引用: 1,001

  6. ANG1005, a Brain-Penetrating Peptide–Drug Conjugate, Shows Activity in Patients with Breast Cancer with Leptomeningeal Carcinomatosis and Recurrent Brain Metastases

    著者: Priya Kumthekar, Shou‐Ching Tang, Andrew Brenner, Santosh Kesari, David Piccioni, Carey K. Anders, Jose Carrillo, Pavani Chalasani, Peter Kabos, Shannon Puhalla, Katherine Tkaczuk, Agustin Garcia, Manmeet S. Ahluwalia, Jeffrey S. Wefel, Nehal J. Lakhani, Nuhad K. Ibrahim - Clinical Cancer Research 2020 被引用: 243

  7. Depatuxizumab mafodotin in EGFR-amplified newly diagnosed glioblastoma: A phase III randomized clinical trial

    著者: Andrew B. Lassman, Stephanie L. Pugh, Tony J. C. Wang, Kenneth Aldape, Hui Gan, Matthias Preusser, Michael A. Vogelbaum, Erik P. Sulman, Minhee Won, Peixin Zhang, Golnaz Moazami, Marian S. Macsai, Mark R. Gilbert, Earle Bain, Vincent Blot, Peter Ansell, Suvajit Samanta, Madan G. Kundu, Terri S. Armstrong, Jeffrey S. Wefel, Clemens Seidel, Filip De Vos, Sigmund Hsu, Andrés F. Cardona, Giuseppe Lombardi, Dmitry Bentsion, Richard A. Peterson, Craig Gedye, Veronique Bourg, Antje Wick, Walter J. Curran, Minesh P. Mehta - Neuro-Oncology 2022 被引用: 147

  8. Memantine for the prevention of cognitive dysfunction in patients receiving whole-brain radiotherapy: a randomized, double-blind, placebo-controlled trial

    著者: Paul D. Brown, S. Pugh, Nadia N. Laack, Jeffrey S. Wefel, Deepak Khuntia, Christina Meyers, Ali Choucair, Sherry Fox, John H. Suh, David Roberge, Vivek S. Kavadi, Søren M. Bentzen, Minesh P. Mehta, Deborah Watkins Bruner, for the Radiation Therapy Oncology Group (RTOG) - Neuro-Oncology 2013 被引用: 944

  9. The addition of androgen deprivation therapy and pelvic lymph node treatment to prostate bed salvage radiotherapy (NRG Oncology/RTOG 0534 SPPORT): an international, multicentre, randomised phase 3 trial

    著者: Alan Pollack, Theodore Karrison, Alexander G. Balogh, Leonard G. Gomella, Daniel A. Low, Deborah Watkins Bruner, Jeffrey S. Wefel, André‐Guy Martin, Jeff M. Michalski, Steve Angyalfi, Himanshu Lukka, Sergio Faria, George Rodrigues, Marie-Claude Beauchemin, R. Jeffrey Lee, Samantha A. Seaward, Aaron M. Allen, Drew C. Monitto, Wendy Seiferheld, Oliver Sartor, Felix Feng, Howard M. Sandler - The Lancet 2022 被引用: 251

  10. Clinical characteristics, pathophysiology, and management of noncentral nervous system cancer‐related cognitive impairment in adults

    著者: Jeffrey S. Wefel, Shelli R. Kesler, Kyle R. Noll, Sanne B. Schagen - CA A Cancer Journal for Clinicians 2014 被引用: 540

  11. Randomized Double-Blind Placebo-Controlled Trial of Bevacizumab Therapy for Radiation Necrosis of the Central Nervous System

    著者: Victor A. Levin, Luc Bidaut, Ping Hou, Ashok Kumar, Jeffrey S. Wefel, B. Nebiyou Bekele, Sujit S. Prabhu, Monica Loghin, Mark R. Gilbert, Edward F. Jackson - International Journal of Radiation Oncology*Biology*Physics 2010 被引用: 722

  12. Acute and late onset cognitive dysfunction associated with chemotherapy in women with breast cancer

    著者: Jeffrey S. Wefel, Angele K. Saleeba, Aman U. Buzdar, Christina A. Meyers - Cancer 2010 被引用: 510

  13. Cognitive adverse effects of chemotherapy and immunotherapy: are interventions within reach?

    著者: Sanne B. Schagen, Andrey S. Tsvetkov, Annette Compter, Jeffrey S. Wefel - Nature Reviews Neurology 2022 被引用: 93

  14. Meta-Analysis of the Efficacy of Virtual Reality–Based Interventions in Cancer-Related Symptom Management

    著者: Yingchun Zeng, Jun-E Zhang, Andy S. K. Cheng, Huaidong Cheng, Jeffrey S. Wefel - Integrative Cancer Therapies 2019 被引用: 125

  15. A prospective phase II randomized trial of proton radiotherapy vs intensity-modulated radiotherapy for patients with newly diagnosed glioblastoma

    著者: Paul D. Brown, Caroline Chung, Diane D. Liu, Sarah McAvoy, David R. Grosshans, Karine A. Al Feghali, Anita Mahajan, Jing Li, Susan L. McGovern, Mary-Fran McAleer, Amol J. Ghia, Erik P. Sulman, Marta Peñas-Prado, John de Groot, Amy B. Heimberger, Jihong Wang, Terri S. Armstrong, Mark R. Gilbert, Nandita Guha‐Thakurta, Jeffrey S. Wefel - Neuro-Oncology 2021 被引用: 114

  16. CODEL: phase III study of RT, RT + TMZ, or TMZ for newly diagnosed 1p/19q codeleted oligodendroglioma. Analysis from the initial study design

    著者: Kurt A. Jaeckle, Karla V. Ballman, Martin J. van den Bent, Caterina Giannini, Evanthia Galanis, Paul D. Brown, Robert B. Jenkins, J. Gregory Cairncross, Wolfgang Wick, Michael Weller, Kenneth Aldape, Jesse G Dixon, S. Keith Anderson, Jane H. Cerhan, Jeffrey S. Wefel, Martin Klein, Stuart A. Grossman, David Schiff, Jeffrey J. Raizer, F. Dhermain, Donald G. Nordstrom, Patrick J. Flynn, Michael A. Vogelbaum - Neuro-Oncology 2020 被引用: 115

  17. Neurocognitive, symptom, and health-related quality of life outcomes of a randomized trial of bevacizumab for newly diagnosed glioblastoma (NRG/RTOG 0825)

    著者: Jeffrey S. Wefel, Terri S. Armstrong, Stephanie L. Pugh, Mark R. Gilbert, Merideth M Wendland, David Brachman, Kevin S. Roof, Paul D. Brown, Ian Crocker, H. Ian Robins, G.K. Hunter, Minhee Won, Minesh P. Mehta - Neuro-Oncology 2021 被引用: 44

  18. The cognitive sequelae of standard‐dose adjuvant chemotherapy in women with breast carcinoma

    著者: Jeffrey S. Wefel, Renato Lenzi, Richard L. Theriault, Robert N. Davis, Christina A. Meyers - Cancer 2004 被引用: 678

  19. Nonpharmacological interventions for cancer-related cognitive impairment in adult cancer patients: A network meta-analysis

    著者: Yingchun Zeng, Juntao Dong, Meiling Huang, Jun-e Zhang, Xiaoming Zhang, Man Xie, Jeffrey S. Wefel - International Journal of Nursing Studies 2020 被引用: 66

  20. The Cognitive Effects of Radiotherapy for Brain Metastases

    著者: Eric J. Lehrer, Brianna M. Jones, Daniel R. Dickstein, Sheryl Green, Isabelle M. Germano, Joshua D. Palmer, Nadia N. Laack, Paul D. Brown, Vinai Gondi, Jeffrey S. Wefel, Jason P. Sheehan, Daniel M. Trifiletti - Frontiers in Oncology 2022 被引用: 65

  21. Whole-Brain Radiotherapy for Brain Metastases: Evolution or Revolution?

    著者: Paul D. Brown, Manmeet S. Ahluwalia, Osaama H. Khan, Anthony L. Asher, Jeffrey S. Wefel, Vinai Gondi - Journal of Clinical Oncology 2017 被引用: 239

  22. Stereotactic Radiosurgery versus Whole-brain Radiation Therapy for Patients with 4-15 Brain Metastases: A Phase III Randomized Controlled Trial

    著者: J. Li, Ethan B. Ludmir, Y. Wang, Nandita Guha‐Thakurta, M.F. McAleer, Stephen H. Settle, D.N. Yeboa, Amol J. Ghia, Susan L. McGovern, Caroline Chung, K.D. Woodhouse, Tina M. Briere, catherine sullaway, D.D. Liu, Ganesh Rao, Eric L. Chang, Anita Mahajan, Erik P. Sulman, Paul D. Brown, Jeffrey S. Wefel - International Journal of Radiation Oncology*Biology*Physics 2020 被引用: 112

  23. Chemotherapy-Related Cognitive Dysfunction

    著者: Jeffrey S. Wefel, Sanne B. Schagen - Current Neurology and Neuroscience Reports 2012 被引用: 394

  24. Nivolumab and ipilimumab with concurrent stereotactic radiosurgery for intracranial metastases from non-small cell lung cancer: analysis of the safety cohort for non-randomized, open-label, phase I/II trial

    著者: Mehmet Altan, Yan Wang, Juhee Song, James W. Welsh, Chad Tang, Nandita Guha‐Thakurta, George R. Blumenschein, Brett W. Carter, Jeffrey S. Wefel, Amol J. Ghia, D.N. Yeboa, Mary Frances McAleer, Caroline Chung, Kristina D. Woodhouse, Susan L. McGovern, Chenyang Wang, Betty Y.S. Kim, Jeffrey S. Weinberg, Tina M. Briere, Yasir Y. Elamin, Xiuning Le, Tina Cascone, Marcelo V. Negrão, Ferdinandos Skoulidis, Renata Ferrarotto, John V. Heymach, Jing Li - Journal for ImmunoTherapy of Cancer 2023 被引用: 27